Predictors of Treatment Response to Biological Medications in Patients with Rheumatoid Arthritis
Background: Rheumatoid arthritis (RA) is a chronic systemic autoimmune inflammatory disease characterized primarily by persistent synovitis, progressive joint destruction, functional impairment, and reduced quality of life. Biological disease-modifying antirheumatic drugs (bDMARDs) have substantially improved the manag...